Positron emission tomography with the deoxyglucose technique and the diagnosis of Alzheimer's disease
Riege and Metter provide a useful review of the application of PET in the evaluation of Alzheimer's disease (AD). We share their enthusiasm for continued support and development of tools to image metabolic processes. Our commentary focuses on neuroimaging and the diagnosis of AD and introduces some new data that directly impacts on the interpretation of PET-2-deoxyglucose (2DG) data. © 1988 Pergamon Journals Ltd.
Digital Object Identifier (DOI)
Additional Document Info
has global citation frequency